NUVB
USDNuvation Bio Inc. Class A Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$5.150
Haut
$5.190
Bas
$3.920
Volume
6.20M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.7B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
7.11M
Bourse
NYQ
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.